Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms [Phase 4]
Phase 4 clinical trial investigating placebo effects in depression and associated cognitive/neural mechanisms in adults with major depressiv…
-
FDA approval · 2018-01-04FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Tranylcypromine sulfate by Actavis Pharma, Inc., resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females [Phase 4]
A Phase 4 clinical trial evaluating 5-hydroxytryptophan and creatine for treatment-resistant depression associated with hypoxia in females h…
-
CLINICAL_TRIALS trial_result · 2017-12-26Clinical Trial Update: Impact of Hot Flashes on Sleep and Mood Disturbance [Phase 4]
Phase 4 trial assessing how hot flashes affect sleep and mood in menopause, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-12-26Clinical Trial Update: Influenza Challenge in Mood Disorders [NA]
Clinical trial update for an influenza challenge study in individuals with major depressive disorder; the study is terminated with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-12-26FDA Approved: DESIPRAMINE HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Desipramine Hydrochloride as an Original Application ANDA by Ingenus Pharmaceuticals, LLC, providing a generic version of the a…
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: The Synchronized Trial on Expectant Mothers With Depressive Symptoms by Omega-3 PUFAs (SYNCHRO) [Phase 3]
Phase 3 clinical trial update for SYNCHRO investigating omega-3 polyunsaturated fatty acids in pregnant women with depressive symptoms; stud…
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment [Phase 2]
Phase 2 randomized trial evaluating CERC-301 as adjunctive treatment for severe depression with active suicidal ideation despite antidepress…
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD [Phase 2]
Phase 2 trial evaluating serotonin transporter availability for prognosis and detection in major depressive disorder has completed with resu…
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: Psilocybin and Depression [Phase 2]
Phase 2 clinical trial update involving psilocybin for severe depression, current status and sponsor information provided.
-
FDA approval · 2017-12-19FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
FDA approval · 2017-12-19FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Vertical Pharmaceuticals, LLC)
The FDA approved a supplemental application for venlafaxine hydrochloride from Vertical Pharmaceuticals, LLC.
-
FDA approval · 2017-12-19FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for desvenlafaxine from Sun Pharmaceutical Industries, updating the drug's approval in some mann…
-
FDA approval · 2017-12-19FDA Approved: FETZIMA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for FETZIMA (levomilnacipran hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2017-12-19FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to introduce an extended-release formulation of Pristiq (desvenlafaxine succinate) from Wyeth Pharma…
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females [Phase 2]
Phase 2 clinical trial evaluating onabotulinumtoxinA for major depressive disorder in adult females has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-19Clinical Trial Update: Survival TRaining for ENhancing Total Health (STRENGTH) [Phase 2]
Phase 2 clinical trial update for STRENGTH study evaluating survival training for overall health in breast cancer and depression populations…
-
FDA approval · 2017-12-14FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Solco Healthcare US LLC)
FDA approved a supplemental application for a generic formulation of bupropion hydrochloride sustained-release (SR) by Solco Healthcare US L…
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Improving Sleep and Psychological Functioning in People With Depression and Insomnia [Phase 4]
Phase 4 trial evaluating interventions to improve sleep and psychological functioning in people with depression and insomnia has completed w…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life. [Phase 4]
A Phase 4 clinical trial evaluated treatments for diabetes and depression in Hispanic and African American participants and assessed effects…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: Guided Self-Help for Depression in Parkinson's Disease [NA]
Completed Rutgers-sponsored trial evaluating guided self-help for depression in people with Parkinson's disease.
-
FDA approval · 2017-12-11FDA Approved: ARIPIPRAZOLE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma's ARIPIPRAZOLE as an original application generic, allowing marketing for the same indications as the reference prod…
-
FDA approval · 2017-12-08FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sertraline hydrochloride submitted by Mylan Pharmaceuticals, likely affecting the product la…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study [NA]
This ClinicalTrials.gov update notes the completion of the Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness study, …
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses [NA]
This ClinicalTrials.gov update indicates that the Johns Hopkins University-sponsored trial 'Peer Support for Increasing Physical Activity in…